Safety and Efficacy Study of a Novel Ointment to Treat Plaque Type Psoriasis
Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of AN2728 Ointment B, 2.0%
and 0.5%, compared to Ointment Vehicle B, applied once or twice daily for 12 weeks, in the
treatment of plaque type psoriasis